KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Total Debt

Short-term and long-term borrowings combined.

KORU Medical Systems, Inc.NASDAQ: KRMD

Total Debt · Q1 FY2026 · quarter ended Mar 2026

Total debt falls 9.8% from a year ago

Total debt stood at $3.37M at the end of Q1 FY2026, down 9.8% from a year earlier and down 3.7% from the prior quarter. Over 3 fiscal years it compounded at -10.8% a year.

Context

  • Total debt amounted to 11.8% of total assets at the end of Q1 FY2026, down 1.9 pp from a year earlier.
  • Total debt increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -9.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.37M-3.7% QoQ
Last fiscal yearDec 2025
$3.5M-12.4% YoY
Year agoMar 2025
$3.73M-9.8% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.8%——
1 year-12.4%——
3-year CAGR-10.8%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
3.5M USD
Year-over-year change
-12.4%
4-year CAGR
+55.1%

Total Debt vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -9.8% is the 7th highest of 10, against a peer median of +3.5%.
  • Total debt amounts to 11.8% of total assets for KRMD, versus a peer median of 10.7%.
KRMD Competitors
Total Debt for KRMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
STIMNeuronetics, Inc.Mar 2026$85.39M USD+3.5%+31.5%68.1%
OSUROraSure Technologies, Inc.Mar 2026$40.47M USD+184.9%+1.7%10.7%
NYXHNyxoah S.A.Mar 2026€36.22M EUR+64.0%+52.4%37.0%
TLSITriSalus Life Sciences, Inc.Mar 2026$34.49M USD+4.1%+159.8%48.6%
INFUInfuSystem Holdings, Inc.Mar 2026$22.77M USD-31.4%-54.7%23.1%
MXCTMaxCyte, Inc.Mar 2026$17.49M USD-7.1%+3.7%9.0%
PROFProfound Medical Corp.Mar 2026$7.49M USD+53.3%-7.8%10.2%
KRMDKORU Medical Systems, Inc.Mar 2026$3.37M USD-9.8%-10.8%11.8%
PREPrenetics Global LimitedMar 2026$457K USD-91.1%-30.8%0.3%
UTMDUtah Medical Products, Inc.Mar 2026$210K USD-21.9%-12.9%0.2%
Peer median (excluding KRMD) —+3.5%+1.7%10.7%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents25.33M17.41M11.48M9.58M8.87M
Short-term Investments00000
Net Receivables3.59M3.56M4.05M6M6.53M
Inventory6.11M6.4M3.48M2.8M3.68M
Other Current Assets718.22K972.4K28.89K749.85K908.54K
Total Current Assets37.32M29.8M20.26M19.13M19.99M
Property, Plant & Equipment (Net)1.2M7.67M7.35M7.26M7.43M
Goodwill00000
Intangible Assets808.81K787.18K754.36K730.28K684.84K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.96M4.07M98.97K98.97K98.97K
Total Non-current Assets3.97M12.53M8.21M8.09M8.21M
Total Assets41.29M42.33M28.46M27.22M28.2M
Account Payables1.23M2.39M975.19K1.65M2.27M
Short-term Debt508.58K433.3K314.34K271.15K538.36K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities90K257.34K512.52K29.27K5.39M
Total Current Liabilities4.79M6.96M4.45M7.2M8.19M
Long-term Debt00002.96M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities01000
Total Non-current Liabilities04.05M3.65M3.2M2.96M
Total Liabilities4.79M11.01M8.11M10.4M11.15M
Common Stock480.44K488.62K490.9K493.78K497.91K
Retained Earnings(910.07K)(9.57M)(23.31M)(29.38M)(32.02M)
Accumulated OCI00000
Other Stockholders Equity(0)(0)(0)00
Minority Interest00000
Total Equity36.5M31.33M20.35M16.81M17.05M
Total Debt604.14K4.93M4.45M3.99M3.5M
Net Debt(24.73M)(12.48M)(7.04M)(5.59M)(5.38M)

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.